EMJ Gastroenterology 9.1 2020

In this issue

Welcome to EMJ Gastroenterology 9.1, an issue that is essential reading for all those interested in novel and emerging therapies for inflammatory bowel disease, stem cell therapies for inflammation-associated sigmoid colon diseases, and other key developments in the field. Inside, we also present summaries of abstracts presented at UEG Week Virtual 2020, as well as interviews with UEG Council representatives.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.